Ultragenyx Pharmaceutical Change in Payables and Accrued Expense (Quarterly) Insights

Ultragenyx Pharmaceutical, Inc. (RARE)

23.40 +0.64 (+2.84%) USD | NASDAQ | Jan 22, 16:00

23.41 +0.02 (+0.06%) After-Hours: 20:00

View Change in Payables and Accrued Expense (Quarterly) for RARE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial